These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 24359972

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
    Prentice BJ, Chelliah A, Ooi CY, Hameed S, Verge CF, Plush L, Widger J.
    J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
    [Abstract] [Full Text] [Related]

  • 5. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
    Haliloglu B, Gokdemir Y, Atay Z, Abali S, Guran T, Karakoc F, Ersu R, Karadag B, Turan S, Bereket A.
    Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
    [Abstract] [Full Text] [Related]

  • 6. Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
    Rakotoarisoa L, Weiss L, Lefebvre F, Porzio M, Renaud-Picard B, Ravoninjatovo B, Abely M, Danner-Boucher I, Dubois S, Troussier F, Prevotat A, Rault G, Kessler R, Kessler L.
    J Diabetes Complications; 2024 Apr; 38(4):108703. PubMed ID: 38430625
    [Abstract] [Full Text] [Related]

  • 7. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
    Taylor-Cousar JL, Janssen JS, Wilson A, Clair CG, Pickard KM, Jones MC, Brayshaw SJ, Chacon CS, Barboa CM, Sontag MK, Accurso FJ, Nichols DP, Saavedra MT, Nick JA.
    J Diabetes Res; 2016 Apr; 2016():1527932. PubMed ID: 27999822
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus.
    Noronha RM, Damaceno N, Muramatu LH, Monte O, Calliari LE.
    Pediatr Diabetes; 2014 Jun; 15(4):309-12. PubMed ID: 24256553
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ, Brenner L, Martin K, Ruazol M, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Putman MS.
    Front Endocrinol (Lausanne); 2024 Jun; 15():1293709. PubMed ID: 38379863
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M, Bilbao Gassó L, Moreno-Galdó A, Campos Martorrell A, Gartner Tizzano S, Yeste Fernández D, Carrascosa Lezcano A.
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [Abstract] [Full Text] [Related]

  • 14. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
    Coriati A, Ziai S, Lavoie A, Berthiaume Y, Rabasa-Lhoret R.
    Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
    [Abstract] [Full Text] [Related]

  • 15. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I, Malet A, Costa M, Brochiero E, Berthiaume Y, Potvin S, Chiasson JL, Coderre L, Rabasa-Lhoret R.
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [Abstract] [Full Text] [Related]

  • 16. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A, Potter KJ, Colomba J, Boudreau V, Bergeron C, Desjardins K, Carricart M, Tremblay F, Lavoie A, Rabasa-Lhoret R.
    Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
    [Abstract] [Full Text] [Related]

  • 17. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
    Chan CL, Pyle L, Vigers T, Zeitler PS, Nadeau KJ.
    J Clin Endocrinol Metab; 2022 Jan 18; 107(2):e548-e560. PubMed ID: 34537845
    [Abstract] [Full Text] [Related]

  • 18. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
    Moreau F, Weiller MA, Rosner V, Weiss L, Hasselmann M, Pinget M, Kessler R, Kessler L.
    Horm Metab Res; 2008 Jul 18; 40(7):502-6. PubMed ID: 18415892
    [Abstract] [Full Text] [Related]

  • 19. Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring.
    Elidottir H, Diemer S, Eklund E, Hansen CR.
    J Cyst Fibros; 2021 Sep 18; 20(5):779-784. PubMed ID: 33478894
    [Abstract] [Full Text] [Related]

  • 20. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
    Foster K, Huang G, Zhang N, Crisalli J, Chini B, Amin R, Elder D.
    Pediatr Pulmonol; 2018 Feb 18; 53(2):154-161. PubMed ID: 29115018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.